(S (NP (NNS Genomics)) (VP (VBP are) (VP (ADVP (RB rapidly)) (VBG transforming) (NP (NP (JJ medical) (NN practice)) (CC and) (NP (JJ basic) (JJ biomedical) (NN research))) (, ,) (S (VP (VP (VBG providing) (NP (NP (NNS insights)) (PP (IN into) (NP (NN disease) (NNS mechanisms))))) (CC and) (VP (VBG improving) (NP (JJ therapeutic) (NNS strategies)) (, ,) (PP (ADVP (RB particularly)) (IN in) (NP (NN cancer)))))))) (. .))
(S (NP (DT The) (NN ability) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (JJ future) (NN course)) (PP (IN of) (NP (NP (DT a) (NN patient) (POS 's)) (NN disease)))) (PP (IN from) (NP (JJ high-dimensional) (JJ genomic) (NN profiling))))))) (VP (VP (MD will) (VP (VB be) (ADJP (JJ essential)) (PP (IN in) (S (VP (VBG realizing) (NP (NP (DT the) (NN promise)) (PP (IN of) (NP (JJ genomic) (NN medicine))))))))) (, ,) (CC but) (VP (NNS presents) (NP (JJ significant) (NNS challenges)) (PP (IN for) (NP (JJ state-of-the-art) (JJ survival) (NN analysis) (NNS methods))))) (. .))
(S (PP (IN In) (NP (DT this) (NN abstract))) (NP (PRP we)) (VP (VBP present) (NP (NP (DT an) (NN investigation)) (PP (IN in) (S (VP (VBG learning) (NP (JJ genomic) (NNS representations)) (PP (IN with) (NP (JJ neural) (NNS networks))) (S (VP (TO to) (VP (VB predict) (NP (NP (JJ patient) (NN survival)) (PP (IN in) (NP (NN cancer)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (NP (NP (DT the) (NNS advantages)) (PP (IN of) (NP (DT this) (NN approach))) (PP (IN over) (NP (NP (VBG existing) (JJ survival) (NN analysis) (NNS methods)) (VP (VBG using) (NP (NN brain) (NN tumor) (NNS data))))))) (. .))
